Gene · 57733
Papers1,720
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,720
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a Risk Nomogram Model for Identifying Interstitial Lung Disease in Patients With Rheumatoid Arthritis. | Front Immunol | 2022 | 35784288 | PubTator, text mining | PubMed |
| Predicting the HIV/AIDS epidemic and measuring the effect of AIDS Conquering Project in Guangxi Zhuang Autonomous Region. | PLoS One | 2022 | 35776707 | PubTator, text mining | PubMed |
| Influence of Nanobubble Size Distribution on Ultrasound-Mediated Plasmid DNA and Messenger RNA Gene Delivery. | Front Pharmacol | 2022 | 35721213 | PubTator, text mining | PubMed |
| mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy. | Front Immunol | 2022 | 35720301 | PubTator, text mining | PubMed |
| Human rs75776403 polymorphism links differential phenotypic and clinical outcomes to a CLEC18A p.T151M-driven multiomics. | J Biomed Sci | 2022 | 35717171 | PubTator, text mining | PubMed |
| Identification of potent inhibitors of arenavirus and SARS-CoV-2 exoribonucleases by fluorescence polarization assay. | Antiviral Res | 2022 | 35716929 | PubTator, text mining | PubMed |
| The antibody-binding Fc gamma receptor IIIa / CD16a is N-glycosylated with high occupancy at all five sites. | Curr Res Immunol | 2022 | 35712026 | PubTator, text mining | PubMed |
| Site-specific glycosylation of SARS-CoV-2: Big challenges in mass spectrometry analysis. | Proteomics | 2022 | 35700310 | PubTator, text mining | PubMed |
| Rapid immunoprecipitation mass spectrometry of endogenous protein (RIME) to identify chromatin-interactome in prostate cancer cells. | STAR Protoc | 2022 | 35693211 | PubTator, text mining | PubMed |
| Exosome: The "Off-the-Shelf" Cellular Nanocomponent as a Potential Pathogenic Agent, a Disease Biomarker, and Neurotherapeutics. | Front Pharmacol | 2022 | 35685643 | PubTator, text mining | PubMed |
| Molecular Markers of Kidney Transplantation Outcome: Current Omics Tools and Future Developments. | Int J Mol Sci | 2022 | 35682996 | PubTator, text mining | PubMed |
| Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET. | Nat Commun | 2022 | 35676290 | PubTator, text mining | PubMed |
| Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates. | Front Immunol | 2022 | 35663946 | PubTator, text mining | PubMed |
| Directing CAR NK Cells via the Metabolic Incorporation of CAR Ligands into Malignant Cell Glycans. | ACS Chem Biol | 2022 | 35648806 | PubTator, text mining | PubMed |
| Cryo-EM structures of human A2ML1 elucidate the protease-inhibitory mechanism of the A2M family. | Nat Commun | 2022 | 35641520 | PubTator, text mining | PubMed |
| GBA1-dependent membrane glucosylceramide reprogramming promotes liver cancer metastasis via activation of the Wnt/β-catenin signalling pathway. | Cell Death Dis | 2022 | 35637196 | PubTator, text mining | PubMed |
| Post-Proline Cleaving Enzymes (PPCEs): Classification, Structure, Molecular Properties, and Applications. | Plants (Basel) | 2022 | 35631755 | PubTator, text mining | PubMed |
| Cherries and Blueberries-Based Beverages: Functional Foods with Antidiabetic and Immune Booster Properties. | Molecules | 2022 | 35630771 | PubTator, text mining | PubMed |
| Evaluating the Effect of Dye-Dye Interactions of Xanthene-Based Fluorophores in the Fluorosequencing of Peptides. | Bioconjug Chem | 2022 | 35622964 | PubTator, text mining | PubMed |
| Transcriptome-Wide Association Studies and Integration Analysis of mRNA Expression Profiles Identify Candidate Genes and Pathways Associated With Ankylosing Spondylitis. | Front Immunol | 2022 | 35619696 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57733/papers?page=17